Some of the most valuable federal relationships don’t start with a proposal. They start with a conversation.
The Shepherd Strategies team is proud to have guided an early-stage technology company through one of the most complex and rewarding paths available to private industry: a direct research partnership with a U.S. Department of Energy national laboratory.
The relationship began the way many of the most productive DOE partnerships do. An informal industry contact connected our client’s leadership with a technical team at a DOE national laboratory chartered to evaluate emerging technologies in its field. The initial engagement was narrow and technical. The lab team was given access to test and benchmark the company’s technology against its own existing systems.
As the two sides worked together, the lab’s interest grew well beyond that first ask. The relationship deepened to the point where lab leadership invited company leadership to present to a broader group of scientists and decision-makers on how DOE facilities could more productively engage small, innovative companies like theirs.
Shepherd Strategies worked alongside the client from that first conversation forward, helping translate early technical interest into a formal Cooperative Research and Development Agreement, or CRADA, with the laboratory.
It meant helping the client understand what the laboratory actually needed to see, how to frame the technology in terms that matched the lab’s mission, and how to keep momentum alive during the months it took to move from an informal introduction to a signed agreement.
From first draft to signed agreement, a fast timeline by CRADA standards
Of active collaborative work following the signature
Both sides contributed time and resources rather than capital
With a license back to the laboratory on any jointly developed work
The two-year figure matters more than it might first appear. National laboratories are, by design, cautious institutions. They are evaluated on mission delivery, not on commercial outcomes for their private partners, and an unfunded agreement carries little of the institutional pressure that keeps government resources moving on a set timeline.
Wherever this engagement made real progress, it traced back to a single lab scientist who was genuinely invested in the technology, not an administrative sponsor simply managing the paperwork. Once that champion was identified, the work moved. Where the relationship depended on the formal agreement alone, it stalled.
The real value emerged from persistence and the right internal relationships inside the lab.
The company’s leadership has been candid that the CRADA itself did not deliver instant results, and that the real value emerged from persistence and the right internal relationships inside the lab. Their assessment, in substance: a signed CRADA gave the company a credibility milestone that mattered to investors and to their own board, and once the right champion inside the lab was engaged, the collaboration produced insight and validation the company could not have generated on its own timeline or budget. That combination, credibility now and technical validation over time, is what leadership has pointed to as the real return on the engagement.
Our role was to ensure the relationship had the best possible chance of succeeding at every stage.
Before the first real conversation, we helped the client reduce a complex technical opportunity into a message that could land inside the narrow window most labs and program offices give a new company.
Once the CRADA was underway, we helped the client build a working relationship centered on the lab’s technical champion rather than on the formal agreement structure alone. And throughout, we helped set realistic expectations with the client’s own leadership and board about what a two-year unfunded engagement would actually look like along the way.
That last piece is easy to underestimate. Companies that treat a signed CRADA as a fast path to revenue tend to lose internal patience exactly when a partnership needs sustained support the most.
Companies that understand it as a long-horizon relationship, one that builds credibility, opens doors, and can eventually lead to funded work or a stronger commercialization position, are the ones who stay engaged through the slow middle stretch where most of these partnerships either find their footing or quietly stall.
A signed CRADA is not a guarantee of technical output. What it is, when the relationship is built and managed well, is a credibility milestone that gives investors and company leadership confidence that a federal partner is taking the technology seriously. For this client, that milestone became a foundation for a continuing relationship with the laboratory and a stronger position from which to pursue further federal engagement.
That approach resonates across more than one audience. Early-stage technology companies, national laboratories, program offices, and the investors backing this kind of innovation all have something to gain from a federal partnership system that works the way it is supposed to, one where promising technology gets a fair, well-structured path from lab validation to real commercial traction. Shepherd Strategies approaches this work the same way we approach every policy environment: by focusing on the facts, building the right relationships, and making a clear, credible case to the people who need to hear it.
The technology was validated. The relationship is still active. And the case for turning a single federal partnership into a lasting commercial advantage has never been easier to make.
At Shepherd Strategies, we specialize in navigating complex regulatory and policy environments to help clients achieve impactful outcomes, whether in national laboratory partnerships, federal funding strategy, economic development, clean energy, or emerging technology commercialization.
© 2026 Shepherd Strategies LLC.
All Rights Reserved.
